Search hospitals > South Carolina > Union
MGC Hematology Oncology-Union
Claim this profileUnion, South Carolina 29379
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
Conducts research for Ovarian Cancer
100 reported clinical trials
11 medical researchers
Summary
MGC Hematology Oncology-Union is a medical facility located in Union, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Ovarian Cancer and other specialties. MGC Hematology Oncology-Union is involved with conducting 100 clinical trials across 268 conditions. There are 11 research doctors associated with this hospital, such as Michael Humeniuk, Amarinthia (Amy) Curtis, Vikas Dembla, and Jeremy M. Kilburn.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Michael HumeniukSpartanburg Medical Center7 years of reported clinical research
Expert in Cancer
Studies Tumors
22 reported clinical trials
40 drugs studied
Amarinthia (Amy) CurtisSpartanburg Medical Center6 years of reported clinical research
Studies Cancer
Studies Breast Cancer
16 reported clinical trials
36 drugs studied
Vikas DemblaSpartanburg Medical Center4 years of reported clinical research
Studies Cancer
Studies Colorectal Cancer
12 reported clinical trials
27 drugs studied
Jeremy M. KilburnGibbs Cancer Center-Pelham2 years of reported clinical research
Studies Tumors
Studies Lung Cancer
7 reported clinical trials
14 drugs studied
Clinical Trials running at MGC Hematology Oncology-Union
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Tumors
Melanoma
Cutaneous Melanoma
Small Cell Lung Cancer
Ovarian Tumors
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at MGC Hematology Oncology-Union?
MGC Hematology Oncology-Union is a medical facility located in Union, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Ovarian Cancer and other specialties. MGC Hematology Oncology-Union is involved with conducting 100 clinical trials across 268 conditions. There are 11 research doctors associated with this hospital, such as Michael Humeniuk, Amarinthia (Amy) Curtis, Vikas Dembla, and Jeremy M. Kilburn.